Oridonin-loaded poly(ε-caprolactone)-poly(ethylene oxide)-poly(ε-caprolactone) copolymer nanoparticles: Preparation, characterization, and antitumor activity on mice with transplanted hepatoma

Journal of Drug Targeting

Volumn 16, Issue 6, 2008, Pages 479-485

  Feng, Nianping ^a   Wu, Peiyi ^b   Li, Qi ^a   Mei, Yinghao ^a   Shi, Shuiping ^a   Yu, Jing ^b   Xu, Jie ^a   Liu, Ying ^a   Wang, Yan ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Antitumor activity; Nanoparticles; Oridonin; PCL PEO PCL

Indexed keywords

COPOLYMER; DRUG CARRIER; ORIDONIN; POLYCAPROLACTONE MACROGOL POLYCAPROLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CARCINOMA, HEPATOCELLULAR; DITERPENES, KAURANE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NEOPLASM TRANSPLANTATION; POLYESTERS; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 47649114092     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802102282     Document Type: Article

References (26)

1. Alakhov, V., Klinski, E., Lemieux, P., Pietrzynski, G. and Kabanov, A. (2001) Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opin Biol Ther, 1:4, pp. 583-602.
2. Cui, Q., Yu, JH, Wu, JN, Tashiro, S., Onodera, S., Minami, M. and Ikejima, T. (2007) P53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin, 28:7, pp. 1057-1066.
3. Ge, H., Hu, Y., Jiang, X., Cheng, D., Yuan, Y., Bi, H. and Yang, C. (2002) Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(ε-caprolactone)-poly(ethylene oxide)-poly(ε-caprolactone) amphiphilic triblock copolymer micelles. J Pharm Sci, 91:6, pp. 1463-1473.
4. Hobbs, SK, Monsky, WL, Yuan, F., Roberts, WG, Griffith, L., Torchilin, VP and Jain, RK (1998) Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci U S A, 95:8, pp. 4607-4612.
5. Hsieh, TC, Wijeratne, EK, Liang, JY, Gunatilaka, AL and Wu, JM (2005) Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochem Biophys Res Commun, 337:1, pp. 224-231.
6. Ikezoe, T., Chen, SS, Tong, XJ, Heber, D., Taguchi, H. and Koeffler, HP (2003) Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol, 23:4, pp. 1187-1193.
7. Jeong, Young-II, Kang, MK, Sun, HS, Kang, SS, Kim, HW, Moon, KS, Lee, KJ, Kim, SH and Jung, S. (2004) All-trans-retinoic acid release from core-shell type nanoparticles of poly(ε-caprolactone)/poly(ethylene glycol) diblock copolymer. Int J Pharm, 273:1, pp. 95-107.
8. Kim, SY and Lee, YM (2001) Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(ε-caprolactone) as novel anticancer drug carriers. Biomaterials, 22:13, pp. 1697-1704.
9. Kim, SY, Lee, YM and Kang, JS (2005) Indomethacin-loaded methoxy poly(ethylene glycol)/poly(,-lactide) amphiphilic diblock copolymeric nanospheres: Pharmacokinetic and toxicity studies in rodents. J Biomed Mater Res A, 74:4, pp. 581-590.
10. Kim, JH, Kim, YS, Park, K., Lee, S., Nam, HY, Min, KH, Jo, HG, Park, JH, Choi, K., Jeong, SY, Park, RW, Kim, IS, Kim, K. and Kwon, IC (2008) Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release, 127:1, pp. 41-49.
11. Kong, G., Braun, RD and Dewhirst, MW (2000) Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res, 60:16, pp. 4440-4445.
12. Li, D., Wu, LJ, Tashiro, S., Onodera, S. and Ikejima, T. (2007) Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells. Biol Pharm Bull, 30:2, pp. 254-260.
13. Ling, C., Li, Q., Liu, X., Chen, Q., Peng, Y., Luo, R. and Huang, X. (2003) Infusion of melittin-poly lactic-co-glycolic acid microspheres via hepatic artery for hepatocarcinoma in rats. World J Gastroenterol, 11:7, pp. 900-903.
14. Maeda, H. (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul, 41, pp. 189-207.
15. Maeda, H., Fang, J., Inutsuka, T. and Kitamoto, Y. (2003) Vascular permeability enhancement in solid tumor: Various factors, mechanisms involved and its implications. Int Immunopharmacol, 3:3, pp. 319-328.
16. Minamimura, T., Sato, H., Kasaoka, S., Saito, T., Ishizawa, S., Takemori, S., Tazawa, K. and Tsukada, K. (2000) Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int J Oncol, 16:6, pp. 1153-1158.
17. Monsky, WL, Fukumura, D., Gohongi, T., Ancukiewcz, M., Weich, HA, Torchilin, VP, Yuan, F. and Jain, RK (1999) Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res, 59:16, pp. 4129-4135.
18. Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y. and Kataoka, K. (2001) Development of the polymer micelle carrier system for doxorubicin. J Control Release, 74:1, pp. 295-302.
19. Okuda, T., Kawakami, S., Akimoto, N., Niidome, T., Yamashita, F. and Hashida, M. (2006) PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Control Release, 116:3, pp. 330-336.
20. Park, EK, Kim, SY, Lee, SB and Lee, YM (2005) Folate-conjugated methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J Control Release, 109:1, pp. 158-168.
21. Park, EK, Lee, SB and Lee, YM (2005) Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials, 26:9, pp. 1053-1061.
22. Xing, J., Zhang, D. and Tan, T. (2007) Studies on the oridonin-loaded poly(d,l-lactic acid) nanoparticles in vitro and in vivo. Int J Biol Macromol, 40:2, pp. 153-158.
23. Zhang, D. and Ren, T. (2003) Pharmacy research review of oridonin. Chin Pharm J, 38:11, pp. 817-820.
24. Zhang, L., Hu, Y., Jiang, X., Yang, C., Lu, W. and Yang, YH (2004) Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release, 96:1, pp. 135-148.
25. Zhou, GB, Chen, SJ, Wang, ZY and Chen, Z. (2007) Back to the future of oridonin: Again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo. Cell Res, 17:4, pp. 274-276.
26. Zhu, Y., Xie, L., Chen, G., Wang, H. and Zhang, R. (2007) Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice. Pharmazie, 62:6, pp. 439-444.